General Catalyst’s Elena Viboch shares medtech predictions for 2023

The venture-capital firm partner talked about the future of AI in radiology and pathology as well as the use of technology in clinical trials.

By Elise Reuter • Feb. 22, 2023

AliveCor says enforcement of Apple Watch import ban may take more than a year

The Biden administration upheld findings that Apple violated AliveCor’s patents, but a potential import ban rests on the outcome of a separate appeal, which could take several months.

By Elise Reuter • Feb. 22, 2023

Explore the Trendline➔

Medical device industry continues to turn to AI

While the industry continues to embrace artificial intelligence, there are still questions about how the new technologies need to be regulated and if they are effective.

By MedTech Dive staff

Philips executives waive bonuses after year of recalls; ex-CEO gets $222,000

The waived incentives coincide with an FDA notice about the recall of some reworked ventilators that Philips initiated late last year.

By Nick Paul Taylor • Feb. 22, 2023

J&J loses bid for Supreme Court review of $302M vaginal-mesh verdict

The justices’ decision to let a lower court verdict stand leaves the company subject to varying state liability laws, J&J says.

By Peter Green • Feb. 21, 2023

Medtronic boosts full-year outlook as supply challenges subside

The medical device maker said its cardiovascular and neuroscience units helped drive quarterly revenue growth.

By Susan Kelly • Feb. 21, 2023

Spinal cord stimulation shows ability to improve motor function in stroke patients in small trial

The spinal implant improved strength, grip force and movement, enabling participants to recover the use of limbs incapacitated by stroke.

By Nick Paul Taylor • Feb. 21, 2023

Device makers gain more time to adapt to Europe’s MDR after EU vote

The European Parliament’s approval means that medtech manufacturers have until 2027 or 2028 to comply with the new rules, depending on device class.

By Susan Kelly • Feb. 17, 2023

Baxter spinoffs move forward as three execs made group presidents in new business structure

The appointments come as the company’s redesigned operating model takes shape ahead of a planned spinoff of its renal care and acute therapies businesses.

By Susan Kelly • Feb. 17, 2023

Henry Schein Q4 profit drops, hurt by falling sales of COVID test kits, PPE

Flu and COVID-19 cases increased appointment cancellations and added to staffing shortages in the quarter.

By Nick Paul Taylor • Feb. 17, 2023

GE’s nuclear imaging device can crush patients, FDA says, as Class I recall issued

GE HealthCare has told customers to stop using the machines until company technicians can inspect them and replace dangerous parts. 

By Nick Paul Taylor • Feb. 17, 2023

Applied Medical suit against Medtronic alleges surgical-device bundling practice curbs competition

Applied says in its filing that Medtronic “has conspired” to bundle devices for cutting tissue and sealing vessels “in a way that is unhealthy for competition.”

By Nick Paul Taylor • Updated Feb. 16, 2023

Robot startup Vicarious is latest medtech company to cut jobs

Medtech layoffs are continuing, with both startups and industry leaders cutting jobs amid changes brought on by higher interest rates and COVID's impact on supply chains and labor costs.

By Susan Kelly • Feb. 15, 2023

Boston Scientific, MDMA call for more transparency and oversight of Medicare Advantage plans

Privately offered Medicare Advantage plans “do not often provide a clear reason for the denial of coverage, and rarely offer any visibility into the evidence and methodology,” trade group MDMA and Boston Scientific said. 

By Nick Paul Taylor • Feb. 15, 2023

Globus’ planned purchase of NuVasive haunted by specter of past spine deals

Past combinations of competing spinal care companies “historically have tended to be messy,” one analyst wrote. Globus’ leaders claim this deal will be different. 

By Elise Reuter • Feb. 14, 2023

Alcon to pay J&J $199M to settle dispute over patents for laser eye surgery device

Alcon is settling the case for far less than the $3.1 billion that J&J’s damages expert argued the company could be owed.

By Nick Paul Taylor • Feb. 14, 2023

Baxter, Abbott, Thermo Fisher among medtech firms cutting jobs on supply issues, slide in testing

"What COVID gave to diagnostics companies, COVID taketh away now that the virus is endemic,” said one analyst.

By Susan Kelly • Updated Feb. 13, 2023

Dexcom secures Medicare coverage for G7 CGM with device set to launch this week

The decision by the CMS will include coverage for people with Type 1 and Type 2 diabetes who are on intensive insulin therapy.

By Elise Reuter • Feb. 13, 2023

Medtronic ordered by jury to pay $106.5M to Colibri over TAVR patent infringement

Medtronic says the ruling will have no effect on its TAVR business as the patents expired last year and it vowed to appeal the verdict. 

By Nick Paul Taylor • Updated Feb. 14, 2023

Patent trolls’ destructive lawsuits are curbing US medtech innovation

The Patent and Trademark Office must help stop frivolous litigation that is harming the industry, argues former HHS secretary Tom Price.

By Tom Price • Feb. 10, 2023

Thermo Fisher cuts additional 230 jobs in California

The job reductions come amid a downturn in demand for COVID-19 tests.

By Susan Kelly • Updated Feb. 10, 2023

82 more deaths linked to Philips’ recalled devices reported to FDA, bringing total to 346

The rate of death reports per month has risen consistently since Philips began the recall in the summer of 2021.

By Nick Paul Taylor • Feb. 10, 2023

Baxter to cut about 3,000 jobs after earnings slump on supply chain woes

The economic slowdown also hurt profit in the period even as the company posted double-digit sales growth.

By Nick Paul Taylor • Feb. 10, 2023

Abbott to pay $890M to acquire CSI, gaining atherectomy device

The deal expands Abbott’s vascular device lineup and access to additional products in development.

By Susan Kelly • Feb. 9, 2023

Abbott balloon device partner Surmodics cuts jobs after FDA approval delay

The workforce reduction, one of a growing number in the medtech sector, comes after the agency requested more data in a premarket review of the company’s device to treat narrowed leg arteries.

By Susan Kelly • Feb. 9, 2023

Medtech CDMO sector poised for M&A rebound in 2023 amid ‘attractive’ targets: report

Manufacturers that serve other industries are expected to move into medtech through mergers and acquisitions, driving up deal volumes.

By Nick Paul Taylor • Feb. 9, 2023